Abstract
Purpose: to detect the clinical and histological effects of preoperative subconjunctival injection of both Bevacizumab and Mitomycin C (MMC) one month before surgical excision of primary pterygium using a bare sclera technique.
Patients and Methods: 20 patients with primary pterygium underwent subconjunctival combined injection of 0.1 ml of MMC (0.2 mg/ml) and 0.1 ml of Bevacizumab (1.25mg/0.1ml ) one month before a bare sclera pterygium excision. The excised pterygium tissues were examined histologically and patients were followed up for at least two years. The excised pterygium of 2 patients without preoperative injection were used for histological comparison.
Results: Clinically There were no recurrence noted during the
Purpose: to detect the clinical and histological effects of preoperative subconjunctival injection of both Bevacizumab and Mitomycin C (MMC) one month before surgical excision of primary pterygium using a bare sclera technique.
Patients and Methods: 20 patients with primary pterygium underwent subconjunctival combined injection of 0.1 ml of MMC (0.2 mg/ml) and 0.1 ml of Bevacizumab (1.25mg/0.1ml ) one month before a bare sclera pterygium excision. The excised pterygium tissues were examined histologically and patients were followed up for at least two years. The excised pterygium of 2 patients without preoperative injection were used for histological comparison.
Results: Clinically There were no recurrence noted during the